Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...
Vertex Pharmaceuticals (VRTX) moved up by 5.3% after it said that the Food and Drug Administration (FDA) approved its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback